Purchase Order HT001423P0275
Award Date 9/29/23
Potential Completion Date 10/29/23
Potential Value $82K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $86,000.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs to Visiopharm Corporation, a foreign-owned for-profit organization based in Denmark. The contract is for the provision of TISSUEARRAY, PHENOMAP, and AI SOFTWARE ADD ON products and services. Visiopharm Corporation, through this contract, will supply digital pathology software, digital microscopes, and biomarker analysis systems to support...
- This federal contract award to Visiopharm Corporation, a foreign-owned, for-profit organization, is for DIGITAL PATHOLOGY ANALYSIS SOFTWARE. The $98,346.00 firm-fixed-price purchase order was awarded by the Veterans Integrated Service Network 20 (VISN 20), a division of the U.S. Department of Veterans Affairs. The contract has an ultimate completion date of October 16, 2017 and does not utilize a set-aside designation. Visiopharm Corporation is a subsidiary of Visiopharm A/S, headquartered in...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20, a civilian agency, to Visiopharm Corporation, a foreign-owned for-profit organization. The contract is for VISIOPHARM EXERCISE OPTION YEAR 2 and has a ceiling value of $12,600.00. Visiopharm Corporation is a wholly-owned subsidiary of Visiopharm A/S, a Danish company specializing in precision pathology software and digital microscopy solutions. This contract is not associated with a larger vehicle...
- Visiopharm Corporation, a foreign-owned for-profit organization, was awarded a $24,775.60 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software with a completion date of February 14, 2025. The award was made on February 15, 2024 without a set-aside designation. Visiopharm will provide its precision pathology software for research and diagnostics, leveraging over 20 years of experience...
- This federal contract award was made by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Visiopharm Corporation, a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions. The $63,750.00 firm-fixed-price purchase order is for VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTIONS and PHENOPLEX SOFTWARE UPGRADES. The contract did not utilize a set-aside designation. Visiopharm Corporation is a wholly-owned...
- The National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, awarded a purchase order contract to Visiopharm Corporation, a foreign-owned, for-profit organization, for a VISIOPHARM DIGITAL PATHOLOGY SUBSCRIPTION. The firm-fixed-price contract has a ceiling value of $68,800.00 and a period of performance ending on July 31, 2025. Visiopharm Corporation, which specializes in precision pathology software and digital microscopy solutions, has previously secured multiple...
- This $97,209.51 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Visiopharm Corporation, a foreign-owned for-profit organization specializing in precision pathology software and digital microscopy solutions. The contract is for the provision of HISTOPATHOLOGICAL AI ANALYSIS SOFTWARE, a set-aside for small businesses. Visiopharm, headquartered in Denmark, has over 20 years of...
- The Defense Health Agency (DHA), a component of the Department of Defense (DoD), awarded a $86,279.63 firm fixed price purchase order to Leica Microsystems Inc.'s Leica Biosystems Division for microscope equipment. The purchase order is to acquire microscope equipment for DHA and will be performed at Leica's place of performance in Silver Spring, Maryland. The period of performance is from September 25, 2023 through November 6, 2023. No subcontractors or set aside designations were identified....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a firm fixed-price purchase order to Visiopharm Corporation, a foreign-owned for-profit organization, for a 3 Biomarker Analysis System. The contract has a potential value of $168,584.91 and a completion date of June 29, 2022. The original procurement was a pre-solicitation announcement seeking Biomarker analysis systems that can detect several forms of cancer using algorithm PD-L1...
- This $79,800.00 firm-fixed-price purchase order from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) awarded to Visiopharm Corporation, a foreign-owned for-profit organization, provides 12-month licenses for Visiopharm's AI-powered image analysis software, Octotopix, and Translational Research Software. The software will support digital pathology and assist pathologists at the NCI's Laboratory of Pathology in analyzing patient tissue samples and providing more...
The U.S. Defense Health Agency (DHA) awarded a $82,190.00 firm-fixed-price purchase order contract to Visiopharm Corporation for the procurement of OCUS40 digital microscopes. The contract has a completion date of October 29, 2023 and was set aside for total small business participation. Visiopharm Corporation is a foreign-owned, for-profit organization specializing in precision pathology software and digital microscopy solutions, and is a wholly-owned subsidiary of the manufacturer Visiopharm A/S. This contract award demonstrates Visiopharm's capability to deliver specialized digital pathology capabilities to support research and diagnostic efforts across federal health and research institutions.
Generated 8/6/24, 10:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.2k | 9/28/23 |